Twana Watkins, in Paragould, AR - Speech-Language Pathologist

Twana Watkins, is a Speech-language Pathologist based in Paragould, Arkansas. Twana Watkins is licensed to practice in * (Not Available) (license number ) and her current practice location is 612 W Mueller, Paragould, Arkansas. She can be reached at her office (for appointments etc.) via phone at (870) 236-6369.

NPI number for Twana Watkins is 1093057069 and her current mailing address is Po Box 3210, Batesville, Arkansas. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1093057069.

Contact Information

	Twana Watkins,
	612 W Mueller, Paragould, AR 72450-5041
	(870) 236-6369
	Not Available

Healthcare Provider's Profile

Full Name	Twana Watkins
Gender	Female
Speciality	Speech-language Pathologist
Location	612 W Mueller, Paragould, Arkansas
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1093057069
Provider Enumeration Date: 03/18/2013
Last Update Date: 01/03/2017

Medical Identifiers

Medical identifiers for Twana Watkins such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1093057069	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	PD10130 (Arkansas)	Secondary
235Z00000X	Speech-language Pathologist	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Twana Watkins is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Twana Watkins, Po Box 3210, Batesville, AR 72503-3210 Ph: () -	Twana Watkins, 612 W Mueller, Paragould, AR 72450-5041 Ph: (870) 236-6369

News Archive

Research suggests latent cytomegalovirus infection exacerbates inflammatory bowel disease

Current research suggests that latent cytomegalovirus (CMV) infection may exacerbate inflammatory bowel disease (IBD). The related report by Onyeagocha et al, "Latent cytomegalovirus infection exacerbates experimental colitis," appears in the November 2009 issue of The American Journal of Pathology.

CytoDyn commences full humanization of Cytolin immune therapy for treating HIV/AIDS

CytoDyn, Inc. has begun full humanization of Cytolin®, the Company's unique immune therapy for treating HIV/AIDS. Although a murine (mouse) version of Cytolin® was used for previous human experience that included some 200 patients successfully treated for up to two years, as well as an encouraging Phase I(b)/II(a) study, the Company believes that a fully-humanized version is necessary for the clinical trial that is expected to follow the current one (described at http://clinicaltrials.gov) for the reasons explained below.

Study shows results of tight glucose control

Here's what we know about controlling blood glucose (blood sugar) in people with diabetes: It's not easy, but it can be done. It requires vigilance and resolve. And it can save your life.

Community OOPPs can improve bystander responses to overdose of heroin

Community opioid overdose prevention programs (OOPPs)-including the use of naloxone for rapid drug reversal-can improve bystander responses to overdose of heroin and related drugs, according to a review in the June Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine.

HCPRA seeks entries for Hollobon Award

The Health Care Public Relations Association (HCPRA) is pleased to announce this year's Call for Entries for The Hollobon Award.

Twana Watkins, - Pharmacist in Paragould, AR